• new product

Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators

PRNewswire March 31, 2023

VIENNA, March 31, 2023 /PRNewswire/ — Croma (Croma-Pharma┬« GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. Read More

Croma-Pharma Logo

Uschi Mayer
External Communications & PR
Cromazeile 2, A-2100 Leobendorf, Austria
M.: +43 676 84 68 68 966
E: uschi.mayer@croma.at


SOURCE Croma-Pharma

AAPR aggregates press releases and media statements from around the world to assist our news partners with identifying and creating timely and relevant news.

All of the press releases published on this website are third-party content and AAP was not involved in the creation of it. Read the full terms.